Jaehoon Ko
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Intravenous Immunoglobulin Replacement Therapy for Persistent COVID-19 in Patients With B-cell Impairment (NCT06159283) | Jaehoon Ko | 2024-03-18 |
Track Jaehoon Ko automatically
Every clearance here is in the API, with alerts when new ones post.